Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous NK Cell”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Testing effectiveness (Phase 2)UnknownNCT02544425
What this trial is testing

VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)

Who this might be right for
Extranodal NK-T-Cell Lymphoma
Samsung Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT01040026
What this trial is testing

Expanded Natural Killer (NK) Cells for Multiple Myeloma Study

Who this might be right for
Multiple Myeloma
University Hospital, Basel, Switzerland 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04836728
What this trial is testing

Phase II Study of Chemotherapy and PD-1 Inhibitor Combination With Autologous CIK Cell Immunotherapy to Treat Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer MetastaticFirst-line Treatment
Tianjin Medical University Cancer Institute and Hospital 156
Testing effectiveness (Phase 2)Study completedNCT00328861
What this trial is testing

Natural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney Cancer

Who this might be right for
Metastatic MelanomaMetastatic Kidney Cancer
National Cancer Institute (NCI) 8
Early research (Phase 1)Study completedNCT03383055
What this trial is testing

CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig

Who this might be right for
LymphomaMultiple Myeloma
Masonic Cancer Center, University of Minnesota 28
Early research (Phase 1)Study completedNCT03515252
What this trial is testing

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

Who this might be right for
NSCLC Stage IIIBNSCLC Stage IVHepatocellular Carcinoma by BCLC Stage+2 more
Ivy Life Sciences, Co., Ltd 20
Testing effectiveness (Phase 2)UnknownNCT02507154
What this trial is testing

Reactivating NK Cells in Treating Refractory Head and Neck Cancer

Who this might be right for
Nasopharyngeal CancerHead and Neck Squamous Cell Carcinoma
National University Hospital, Singapore 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994
What this trial is testing

A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory Neuroblastoma

Who this might be right for
NeuroblastomaGD2 AntibodyAutologous NK Cell
Guangzhou Women and Children's Medical Center 15
Testing effectiveness (Phase 2)UnknownNCT02215837
What this trial is testing

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Who this might be right for
Gastric CancerNeoplasmsGastrointestinal Neoplasms+2 more
Shenzhen Hornetcorn Bio-technology Company, LTD 40
Not applicableStudy completedNCT00536601
What this trial is testing

High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+56 more
Roswell Park Cancer Institute 174
Not applicableLooking for participantsNCT05676190
What this trial is testing

Clinical Study on the Efficacy of Autologous Cell Factor Induced Killer Cells in the Treatment of Colorectal Cancer

Who this might be right for
Colorectal Cancer
ShiCang Yu 80
Early research (Phase 1)Study completedNCT01588769
What this trial is testing

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma Multiforme
CytoVac A/S 23
Early research (Phase 1)Study completedNCT03894579
What this trial is testing

Autologous Natural Killer Cells in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
NKGen Biotech, Inc. 9
Early research (Phase 1)Study completedNCT07271446
What this trial is testing

An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Precision Biotech Taiwan Corp. 8
Early research (Phase 1)Study completedNCT02271711
What this trial is testing

Expanded Natural Killer Cell Infusion in Treating Younger Patients With Recurrent/Refractory Brain Tumors

Who this might be right for
Recurrent Childhood MedulloblastomaRecurrent EpendymomaRecurrent Medulloblastoma
M.D. Anderson Cancer Center 12
Early research (Phase 1)Study completedNCT02481934
What this trial is testing

Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma

Who this might be right for
Multiple Myeloma
Joaquín Martínez López, MD, PhD 5
Testing effectiveness (Phase 2)UnknownNCT01655628
What this trial is testing

GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Stage IV Nasopharyngeal Carcinoma
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT03360630
What this trial is testing

Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC

Who this might be right for
Lung CancerNeoplasms
Capital Medical University 60
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Testing effectiveness (Phase 2)WithdrawnNCT01533727
What this trial is testing

CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University
Load More Results